Drug Trial Radar · NCT06529445
Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects
Last checked: Nov 19, 2026Latest source record: Aug 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
84
Actual
Start
Jul 22, 2024
Primary completion
Aug 26, 2024
Study completion Aug 26, 2024
Sponsor
- Lead sponsor
- Jiangsu vcare pharmaceutical technology co., LTDIndustry
- Sponsor type
- Industry
- First posted
- Jul 31, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will adopt a randomized, open-label, two-period, 2-way crossover design to evaluate Food effect and Relative bioavailability of VC004 Capsules in healthy subjects
Conditions
- Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Interventions
High Dose VC004 CapsulesDrug
VC004 Capsules qd per period, for two periods
Median Dose VC004 CapsulesDrug
VC004 Capsules qd per period, for two periods
Low Dose VC004 CapsulesDrug
VC004 Capsules qd per period, for two periods
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Observed Plasma Concentration (Cmax)Time frame: Day1-Day7
- Peak time(Tmax)Time frame: Day1-Day7
- Area Under the Curve From Time Zero to Last Quantifiable Concentration(AUC)Time frame: Day1-Day7
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Zhongda Hospital,Affiliated to Southeast University
Nanjing, Jiangsu, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.